Nulixir Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
23
- Latest Deal Type
-
Series A1
- Latest Deal Amount
-
$10M
- Investors
-
6
Nulixir General Information
Description
Developer of food-grade nanovesicles designed to mask functional ingredients' flavors and tune their performance in the body. The company develops, manufactures, and licenses intellectual property (IP) for smart nanocarriers, called nanovesicles, which optimize the performance of functional ingredients in food and beverage products, enabling food companies to elevate the potential of their brand by improving taste, offering new functionalities and presenting new benefits.
Contact Information
Website
www.nulixir.comCorporate Office
- 8609 Cross Park Drive
- Austin, TX 78754
- United States
Corporate Office
- 8609 Cross Park Drive
- Austin, TX 78754
- United States
Nulixir Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A1) | 19-Dec-2023 | $10M | Completed | Generating Revenue | ||
| 1. Early Stage VC | 01-Jan-2022 | Completed | Generating Revenue |
Nulixir Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A-2 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Nulixir Patents
Nulixir Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025221702-A1 | Particles for delivery of substances | Pending | 14-Apr-2024 | ||
| US-20240165036-A1 | Encapsulated vitamin d | Pending | 09-Aug-2022 | ||
| AU-2022345789-A1 | Alimentary-related particles, production methods, and production apparatus | Pending | 14-Sep-2021 | ||
| CA-3231913-A1 | Alimentary-related particles, production methods, and production apparatus | Pending | 14-Sep-2021 | ||
| EP-4401713-A1 | Alimentary-related particles, production methods, and production apparatus | Pending | 14-Sep-2021 | A61K9/4875 |
Nulixir Signals
Nulixir Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Conti Ventures | Venture Capital | Minority | ||
| Fall Line Capital | Venture Capital | Minority | ||
| F-Prime | Venture Capital | Minority | ||
| Middleland Capital | Venture Capital | Minority | ||
| Praesidium (Luxembourg) | Asset Manager | Minority |
Nulixir FAQs
-
When was Nulixir founded?
Nulixir was founded in 2019.
-
Where is Nulixir headquartered?
Nulixir is headquartered in Austin, TX.
-
What is the size of Nulixir?
Nulixir has 23 total employees.
-
What industry is Nulixir in?
Nulixir’s primary industry is Specialty Chemicals.
-
Is Nulixir a private or public company?
Nulixir is a Private company.
-
What is the current valuation of Nulixir?
The current valuation of Nulixir is .
-
What is Nulixir’s current revenue?
The current revenue for Nulixir is .
-
How much funding has Nulixir raised over time?
Nulixir has raised $14.8M.
-
Who are Nulixir’s investors?
Conti Ventures, Fall Line Capital, F-Prime, Middleland Capital, and Praesidium (Luxembourg) are 5 of 6 investors who have invested in Nulixir.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process